Portrait of Evanthia Roussos Torres, MD PhD
← Back to team

Evanthia Roussos Torres, MD PhD

Assistant Professor of Medicine and Cancer Biology at the Keck School of Medicine of USC. Her lab studies breast cancer immune-oncology, and she treats patients with breast cancer at Los Angeles General Medical Center and USC Norris.

Biography

Assistant Professor of Medicine and Cancer Biology at USC.

Evanthia Roussos Torres is an Assistant Professor in the Department of Medicine (Division of Oncology) and the Department of Cancer Biology at the Keck School of Medicine of USC, and a member of the USC Norris Comprehensive Cancer Center — where she co-leads the Tumor Immunology & Microenvironment Program and serves as Assistant Director of Cancer Research Training and Education Coordination.

Her laboratory studies why breast cancers resist immunotherapy and how to overcome that resistance. The lab focuses on myeloid-derived suppressor cells (MDSCs) and other immunosuppressive programs in the tumor microenvironment, including epigenetic modulation, immune checkpoint inhibition, metastatic-site differences, and patient-population differences.

She earned her MD and PhD at the Albert Einstein College of Medicine, trained in internal medicine and hematology/oncology at the University of Pennsylvania, and completed her medical oncology fellowship at Johns Hopkins in the laboratory of Elizabeth Jaffee. Today she treats patients with breast cancer at Los Angeles General Medical Center and USC Norris, and mentors trainees from high school through faculty.

Appointments & leadership

Academic

Assistant Professor

Department of Medicine (Division of Oncology) & Department of Cancer Biology, Keck School of Medicine of USC, with secondary appointments in Molecular Microbiology & Immunology and Cancer Biology.

USC faculty profile
Cancer center

Co-Leader, Tumor Immunology & Microenvironment Program

USC Norris Comprehensive Cancer Center. Also Assistant Director, Cancer Research Training & Education Coordination (CRTEC).

USC Norris program
Clinical

Attending Physician, Breast Medical Oncology

Los Angeles General Medical Center and USC Norris — Keck School of Medicine.

Breast cancer care
National service

NCI Study Section — Permanent Member

Translational Immune-Oncology study section (2026–2030). Associate Editor, Breast Cancer Research.

NIH study section

Education & training

2000–05

University of California, Los Angeles

B.A. and B.S. — Magna cum laude

2005–12

Albert Einstein College of Medicine

M.S., then M.D.–Ph.D. — With distinction

2012–16

Hospital of the University of Pennsylvania

Residency, Internal Medicine; Fellowship, Hematology/Oncology

2016–18

Johns Hopkins University School of Medicine

Fellowship, Medical Oncology — laboratory of Elizabeth Jaffee

Honors & awards

show
2025

Jane E. Gray Travel Fellow Award

35th Annual Breast Cancer Think Tank

2025

GRASP Advocate Choice Award

Selected for oral presentation to the advocacy community

2024

Best Poster Presentation, Grantee Summit

American Association for Cancer Research

2024

Grantee Poster Session Winner

American Association for Cancer Research

2023

Rising Star Scientific Investigator Award

Albert Einstein College of Medicine

2022

Career Development Award

METAvivor

2021

Minnie Riperton Legacy Award

Concern Foundation

2020

Career Development Award

Tower Cancer Research Foundation

2020

Conquer Cancer Young Investigator Award

Concern Foundation

2018

Scholar-in-Training Award

American Association for Cancer Research

2017

Physician Scientist Training Program — Scholars Class Inductee

Johns Hopkins University

2012

Dean’s Recognition Award

Albert Einstein College of Medicine

2010

Louis and Rachel Rudin Scholar

Albert Einstein College of Medicine

2009

Scientific work displayed at the White House

Albert Einstein College of Medicine

Research funding

NIH/NCI · R01

Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer

NIH/NCI · U01

Exploring the dynamic tumor-immune ecosystem of breast cancer in heterogeneous tumor microenvironments

Co-Principal Investigator

NIH/NCI · P20

The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer

BCRF

Suppressing suppression: a myeloid-centric approach to an anti-tumor response

Breast Cancer Research Foundation — Next Gen

B-Search

Suppressing suppression: a myeloid-centric approach to an anti-tumor response

B-Search Foundation

Past support includes METAvivor, the Tower Cancer Research Foundation, the Concern Foundation, and USC pilot programs.

visibility and talks

show
2026

Organ-specific innate immunity in metastatic breast cancer

Conference — Salt Lake City, UT

2025

Beyond RECIST: the role of mathematical modeling in tumor immunology

Breast Cancer Research Foundation Scientific Meeting — New York, NY

2025

The role of myeloid suppression in immune response and metastatic progression

Breast Cancer Think Tank — Caribbean

2024

Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer

International Cancer Immunotherapy Conference — Washington, DC

2024

Myeloid suppression as a driver of intrinsic immune resistance in breast cancer

University of Maryland School of Medicine — Baltimore, MD

2023

Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer

Metastatic Breast Cancer Research Conference — Park City, UT

2023

Modulating MDSC function to alter responses to checkpoint inhibition

MD Anderson Cancer Center — invited seminar

2022

Suppressing suppression: a myeloid-centric approach to immune sensitization

UT Southwestern, Simmons Comprehensive Cancer Center — Dallas, TX

2022

Suppressing suppression: a myeloid-centric approach to immune sensitization

Shenzhen International Hematology & Oncology Summit — International

2021

Entinostat, nivolumab and ipilimumab in advanced breast cancer

ESMO Congress — Paris, France (International)

2019

Unlocking the immune potential of breast cancer through reprogramming of the suppressive microenvironment

Guy’s Cancer Centre, King’s College London — United Kingdom (International)

Service & editorial

Editorial

Associate Editor, Breast Cancer Research

Basic Research section (2026–)

Peer review

NCI/NIH Translational Immune-Oncology Study Section

Permanent Member, 2026–2030

Advisory

Scientific Advisory Board, Tower Cancer Research Foundation

Planning

San Antonio Breast Cancer Symposium — Planning Committee

2026–

Journals

Reviewer for AACR journals, the Journal of Clinical Investigation, Nature Communications, and others

Professional societies

  • American Association for Cancer Research
  • American Society of Clinical Oncology
  • Society for Immunotherapy of Cancer
  • Metastasis Research Society
  • SWOG Cancer Research Network
  • California Cancer Consortium